Share
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
NEW ENGLAND JOURNAL OF MEDICINE
Kantarjian, H; Shah, NP; Hochhaus, A; Cortes, J; Shah, S; Ayala, M; Moiraghi, B; Shen, ZX; Mayer, J; Pasquini, R; Nakamae, H; Huguet, F; Boque, C; Chuah, C; Bleickardt, E; Bradley-Garelik, MB; Zhu, C; Szatrowski, T; Shapiro, D; Baccarani, M, 2010: Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia. NEW ENGLAND JOURNAL OF MEDICINE 362(24), p. 2260 - 2270, doi: 10.1056/NEJMoa1002315
CEITEC authors: